Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer

Conclusion: High pretreatment GPS is independently associated with worse OS in patients with advanced NSCLC. GPS should be considered in patient counseling and decision-making and needs to be further validated by large-cohort and prospective studies.

http://www.jcancer.org/v12p2395.htm

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Mingmei Pan, Yun Zhao, Jianbo He, Huanqiong Wu, Yujia Pan, Qitao Yu, Shaozhang Zhou Tags: Research Paper Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Study